https://pipelinereview.com/Everest-Medicines-Announces-Partner-Providence-Reports-Positive-Top-Line-Data-from-Phase-2-Primary-Immunization-Trial-for-mRNA-COVID-19-Vaccine-Candidate-in-Adults/